Presentation Information
[JG-16]Oclacitinib suppresses disease progression in an immune-mediated diabetes mouse model
○Ayane Saito1, Kenjiro Kaji2, Kazuhisa Kishi3, Masatoshi Hori3, Noriyuki Kaji1 (1. Laboratory of Veterinary Pharmacology, School of Veterinary Medicine, Azabu University, 2. Department of pharmacology, Tokyo Women's Medical University, 3. Department of Veterinary Pharmacology, Graduate School of Agricultural and Life Sciences, The University of Tokyo)